Germany, for two months, first results are expected from testing the vaccine against Coronacterius

The first test results of the vaccine against coronarys, which the company develops “Kirvac” (CureVac) is expected for two months, broadcast today the German page “Fokus online”.

The biofarmacetic company has published earlier this week that the first significant results could be accessible in September or October, and if the conditions are convenient, the vaccine could get approval by the middle of next year, transfer kp.

It has earlier been reported that CureVas has taken pleasure in her candidate's clinical examination of the choreography vaccine. The biofarmacetic firm also works in the so - called mRNK vaccine that stimulates human cells after vaccinating to produce protein that would exclude the coronary.